New York City, New York 10016


Purpose:

To determine if the addition of Astym treatment to traditional therapy produces a more positive outcome then traditional therapy alone for the treatment of de Quervain's tenosynvitis. Two groups will be examined with one group receiving traditional therapy and the other group receiving traditional therapy in addition to Astym treatment protocol.


Criteria:

Inclusion Criteria: i. Positive Finkelstein's test: The client will report pain over the first compartment of the extensor retinaculum when the thumb is tucked in the hand and deviated ulnarly. ii. Persistent symptoms for >3 wks which have not resolved after an additional 3 weeks of splinting iii. A diagnosis by a physician of "de Quervain's", "fist compartment tenosynovitis", or "radial styloid tenosynovitis" iv. Patients must agree and comply to a predetermined splinting regimen Exclusion Criteria: i. History of cortical steroid injection to affected wrist and/or thumb ii. History of previous wrist trauma to affected limb iii. Comorbidity such as carpal tunnel syndrome (CTS), radial tunnel syndrome, osteoarthritis, rheumatoid arthritis, auto-immune disease or inflammatory conditions, lateral epicondylitis or tendinopathies iv. Clotting deficits v. Positive Cozen's sign which would indicate intersection syndrome vi. Post-partum mothers <6 months and pregnant women


NCT ID:

NCT02442622


Primary Contact:

Principal Investigator
Stephen VanLew, MS, OTR/L
NYU Langone Medical Center

April O'Connell, OTR/L, CHT
Phone: (646) 501-7077
Email: April.Davis@nyumc.org


Backup Contact:

N/A


Location Contact:

New York City, New York 10016
United States

April O'Connell, OTR/L,CHT
Phone: 646-501-7707
Email: April.Davis@nyumc.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.